ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.

Muling Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.